Skip to Main ContentSkip to FooterSkip to Search
Contact Us
Contact Us
Main menu

How can we work together

ORAL
BIOLOGICS
CELL & GENE THERAPY
CLINICAL SUPPLY
CONSUMER

Latest News

Catalent Adds New Cryogenic Capabilities at Shiga, Japan, Facility to Support Clinical Supply Demand for Cell and Gene Therapy Development

JUST RELEASED: CORPORATE RESPONSIBILITY REPORT
To learn more about progress against our corporate responsibility and sustainability strategy, please review our Fiscal 2022 Corporate Responsibility Report.
VIEW REPORT
SITE TOURS
Explore our facilities through new 360° Virtual Site Tours and Site Tour Videos to get a window into our integrated services, superior drug delivery technologies and manufacturing solutions across the globe.
INTRODUCING PROTEOSUITE℠ ORAL
A comprehensive toolkit that offers a developability assessment specific to protein degraders to help identify orally bioavailable candidates and leverage an array of specialized capabilities to select the right formulation to efficiently get to clinic and beyond.
GLOBAL NETWORK
With our broad range of experience and deep expertise, we have the talent and unique technologies to transform your concepts into excellent results. This is backed by our global reach, with facilities located worldwide enabling us to tailor a solution to fit your needs.
SEE ALL LOCATIONS
JOIN OUR TEAM
Catalent is growing & hiring! Join the global drug development and delivery leader that puts “Patient First” at the center of our work every day. Learn more about careers at Catalent.
VIEW ALL NEWS
VIEW ALL EVENTS

EXPERT CONTENT

CDMO Playbook and Strategies for Scaling the Emerging Biotech

Developing Optimized Formulations with Minimal Drug Substance

Concept to Dosing: Challenges in New Orphan Drugs

Pharmaceutical Outsourcing for Oral Development & Manufacturing

Enabling Successful Scale-Up of a Spray Drying Program

Is My Molecule Suitable for an Orally Disintegrating Tablet?

Emerging Trends and Opportunities in Orally Inhaled Drug Products

VIEW ALL ARTICLES